AccueilPodcastsThe Long Run with Luke TimmermanEp190: Neil Kumar on Building a Rare Disease Drug CompanyThe Long Run with Luke TimmermanEp190: Neil Kumar on Building a Rare Disease Drug Company20 novembre 2025 · 1 h 13 minLire l’épisodePartager à partir d’iciNotes de l’épisodeNeil Kumar is founder and CEO of Palo Alto, Calif.-based BridgeBio Pharma, a rare disease drug developer.Tous les épisodes de The Long Run with Luke Timmerman